Cargando…
N‐glycosylated GPNMB ligand independently activates mutated EGFR signaling and promotes metastasis in NSCLC
Lung cancer is the leading cause of cancer‐related death worldwide. As well as the identified role of epidermal growth factor receptor (EGFR), its association with driver mutations has improved the therapeutics for patients with lung cancer harboring EGFR mutations. These patients usually display sh...
Autores principales: | Han, Chia‐Li, Chen, Xuan‐Ren, Lan, Albert, Hsu, Yuan‐Ling, Wu, Pei‐Shan, Hung, Pei‐Fang, Hung, Chung‐Lieh, Pan, Szu‐Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088973/ https://www.ncbi.nlm.nih.gov/pubmed/33706413 http://dx.doi.org/10.1111/cas.14872 |
Ejemplares similares
-
Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC
por: Ju, Jia-Shiuan, et al.
Publicado: (2023) -
Mitochondrial translocation of EGFR regulates mitochondria dynamics and promotes metastasis in NSCLC
por: Che, Ting-Fang, et al.
Publicado: (2015) -
The impact of EGFR mutations on the incidence and survival of stages I to III NSCLC patients with subsequent brain metastasis
por: Chang, Wei-Yuan, et al.
Publicado: (2018) -
The Role of GPNMB in Inflammation
por: Saade, Marina, et al.
Publicado: (2021) -
CCN3/NOV promotes metastasis and tumor progression via GPNMB-induced EGFR activation in triple-negative breast cancer
por: Son, Seogho, et al.
Publicado: (2023)